CagriSema’s blood sugar and weight reductions exceeded the company’s blockbuster Wegovy, yet the drug might still struggle to ...
Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...
Wave claimed GSK is walking away from the frontrunning program not because of questions about its potential, but because Wave ...
The drug, which has suffered multiple setbacks over the years, could finally reach the market as a treatment for a form of Gaucher disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results